ational Endoscopic ultrasound portal pressure gradient registry

Not Applicable

Recruiting

• Conditions: Hepatic disease; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12623000031662
• Lead Sponsor: Royal Brisbane & Women's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-12
• Last Update Posted: 16 January 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

All consenting participants having and endoscopic ultrasound - portal pressure gradient (EUS-PPG) assessment will be included in this prospective registry.

Exclusion Criteria

No exclusion criteria. All patients who are referred for this intervention will be approached to consent to have their data entered into the Registry.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All participants will undergo an endoscopic assessment of portal hypertension, which includes an endoscopy and EUS. EUS-PPG measurement will be performed by endosonographers trained in EUS-PPG, using the Echotip Ultra device (Cook Medical), which comprises a 25gauge FNA-needle, 90cm non-compressible tubing and a manometer. <br>[Baseline -during endoscopic ultrasound (EUS) procedure]